Google+ Facebook Twitter Twitter

Tech news: March 2022

This month's top tech news stories

BIOHIT HealthCare

Atrophic gastritis

A clinical validation study has confirmed the high accuracy of BIOHIT Oyj’s new-generation GastroPanel test for the diagnosis of atrophic gastritis (AG) and Helicobacter pylori (Hp) infection in patients referred for gastroscopy.

The test is designed for the first-line diagnosis of Hp infection and AG in patients with upper abdominal symptoms, such as dyspepsia and gastro-oesophageal reflux disease, before endoscopy.



Université de Paris has installed a Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform. One of the most prestigious universities in France, known for its cutting-edge research in medicine and more broadly biology and health, is the first facility in the country to benefit from an IVDr instrument of this kind. MetaboParis-Santé is upheld as a national centre of excellence for metabolic analysis by NMR of human biofluids.


Cancer drug

CellCentric, a clinical-stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, has received funding from BrightEdge, the impact venture capital fund of the American Cancer Society.

The funding will be used to further progress the clinical development of its ground-breaking, targeted treatment, inobrodib (formerly known as CCS1477). Inobrodib is a first-in-class small molecule inhibitor that impacts twin regulatory proteins p300 and CBP and affects a number of established, yet elusive-to-treat oncogenes.

Image Credit | Shutterstock

Related Articles

Race to reveal the secret of life

The work of scientists from many disciplines led to the discovery of the double helix, 70 years ago. It has shaped biomedical science ever since.

Tech news: September

This month's top tech news stories

AI model to determine where cancer originated

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment, because many cancer drugs are typically developed for specific cancer types.

New tool for medical biosensors

A team of US researchers have developed a new method using nanopores — nanometre-sized holes — to help scientists advance their discoveries in neuroscience and other medical applications.